DarioHealth Corp DRIO

NAS: DRIO | ISIN: US23725P2092   30/04/2025
0,715 USD (-0,64%)
(-0,64%)   30/04/2025

1 mei 2025 · DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives · Persbericht

21 april 2025 · DarioHealth Announces CFO Transition · Persbericht

17 april 2025 · DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers · Persbericht

8 april 2025 · Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion · Persbericht

17 maart 2025 · /C O R R E C T I O N -- DarioHealth Corp./ · Persbericht

10 maart 2025 · DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results · Persbericht

7 maart 2025 · Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula · Persbericht

5 maart 2025 · Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth · Persbericht

4 maart 2025 · DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025 · Persbericht

12 september 2024 · Dario Introduces Integration of Twill Behavioral Health Capabilities into Cardiometabolic Health Solution to Enhance Member Engagement and Outcomes · Persbericht

10 september 2024 · Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes · Persbericht

8 augustus 2024 · DarioHealth Reports Second Quarter 2024 Financial and Operating Results · Persbericht

30 juli 2024 · DarioHealth to Report Second Quarter 2024 Results on Thursday, August 8th · Persbericht

16 juli 2024 · Dario Expands GLP-1 Solution Client Base with New Employer Contract · Persbericht

25 juni 2024 · Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 · Persbericht

5 juni 2024 · Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer · Persbericht

15 mei 2024 · DarioHealth Reports First Quarter 2024 Financial and Operating Results · Persbericht

7 mei 2024 · DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th · Persbericht

25 april 2024 · Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes · Persbericht

18 april 2024 · Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution · Persbericht

Mijn selecties